Clinical Trials
7
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (100.0%)Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological
Not Applicable
Not yet recruiting
- Conditions
- Cognitive Functions Perceptual DisturbancesCognitive Function AbnormalSleepPsychological
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- SunWay Biotech Co., LTD.
- Target Recruit Count
- 50
- Registration Number
- NCT06968299
- Locations
- 🇨🇳
Tri-Service General Hospital, National Defense Medical Center, Taipei city, Taiwan
Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants
Not Applicable
Recruiting
- Conditions
- Body WeightBody FatOverweight
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- SunWay Biotech Co., LTD.
- Target Recruit Count
- 100
- Registration Number
- NCT05869799
- Locations
- 🇨🇳
Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan
Effect of ANKASCIN 568-P Products Regulating Blood Lipid
Not Applicable
Not yet recruiting
- Conditions
- Hyperlipidemias
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- SunWay Biotech Co., LTD.
- Target Recruit Count
- 80
- Registration Number
- NCT05737355
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
Not Applicable
Not yet recruiting
- Conditions
- High Blood SugarMetabolic Syndrome
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- SunWay Biotech Co., LTD.
- Target Recruit Count
- 80
- Registration Number
- NCT05737342
The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial
Not Applicable
Not yet recruiting
- Conditions
- Atopic DermatitisAtopic Dermatitis Eczema
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- SunWay Biotech Co., LTD.
- Target Recruit Count
- 72
- Registration Number
- NCT05719649
- Prev
- 1
- 2
- Next
News
No news found